JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation is allowed to use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website for educational purpose only. Bodily introduction of any kind into humans and animals is strictly forbidden by law. This product should only be handled by licenced qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused as a drug, food and cosmetic.
FREE Shipping for orders over $200
Finasteride is a specific inhibitor of 5α-reductase, the enzyme responsible for conversion of testosterone to dihydrotestosterone (DHT), the more potent androgen. This enzyme activity has been widely studied in biochemical and endocrinological research related to the signaling pathways linked with androgen actions and regulation of steroidal hormones. Through mediated control of DHT production, finasteride is used as a molecular tool to investigate androgen receptor (AR) activation, tissue-specific AR responsiveness and hair follicle-related cellular signaling pathways.
Finasteride was first identified and approved by FDA as Proscar in 1992 for benign prostatic hyperplasia investigation and then for Propecia in 1997 as relating to resistant hair follicle studies. Current research applications also explore its effects on hormonal regulation and endocrine pathway dynamics. At Element CRP, finasteride for sale is supplied exclusively for laboratory, analytical, and educational research purposes and is not intended for clinical, therapeutic, or human consumption.
From Pubchem
IUPAC Name:(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamideSynonyms: Proscar, Propecia, FinastidMolecular Formula: C23H36N2O2Molecular Weight: 372.5 g/molCAS Number: 98319-26-7PubChem CID: 57363
Finasteride is a 5α-reductase inhibitor, which inhibits the conversion of testosterone to dihydrotestosterone (DHT), a potent androgen. In biochemical and endocrinology investigations, it is employed to study the androgen dependent signaling pathways, activation of the androgen receptor and tissue-specific responsiveness. Cell-based models, such as prostate-derived cells, have addressed the effects of finasteride on DHT synthesis and subsequent molecular pathways associated with androgen-dependent transcriptional activity [1, 2].
In mechanistic studies, the action of androgens on hair follicle biology has been examined using finasteride. Investigations have also included the study of the effect of DHT modulation on hair follicle miniaturization, follicular growth cycles, and receptor-mediated gene expression in cultured follicular keratinocytes or scalp tissue systems for in vitro research [3, 4, 5, 6]. Systemic versus localised exposure, and hair follicle androgen sensitivity have been addressed in formulation-specific studies.
Finasteride has been employed in research to study hyperandrogenic cellular conditions and androgen receptor–mediated processes. Experimental investigations have assessed the effects of 5α-reductase inhibition on androgen-responsive gene expression, receptor signaling dynamics, and cellular morphology in model systems designed to mimic androgen-regulated tissue environments [7].
Mechanistic studies have explored finasteride’s influence on ocular physiology, particularly in model systems investigating steroid-mediated signaling in the choroid and retina. Research has quantified molecular endpoints such as fluid dynamics, subcellular compartmentalization, and tissue-specific androgen signaling following 5α-reductase inhibition [8, 9]. These studies provide insights into androgen-regulated ocular cellular mechanisms.
Finasteride is a widely studied 5α-reductase inhibitor used as an experimental tool to probe androgen-dependent signaling, receptor activation, and tissue-specific androgen responsiveness. At Element CRP, liquid finasteride is provided strictly for laboratory, analytical, and educational research purposes. It is not intended for clinical, therapeutic, or human use. Only qualified researchers should buy finasteride under controlled research conditions.
Finasteride is a small-molecule 4-azasteroid 5-alpha reductase inhibitor with selective binding at the type II isoform of the enzyme. Its steroidal structural features support reliable activity in cell culture buffer systems and reproducible behaviour across in vitro 5-AR pharmacology research applications.
Cell-based research with Finasteride examines 5-alpha reductase type II inhibition with downstream effects on the androgen biosynthesis pathway in prostate epithelial cell models, dermal papilla cell preparations, and recombinant enzyme systems. Standard readouts include conversion rate assays measuring testosterone-to-DHT activity and IC50 determination across cell line backgrounds.
Element CRP supplies this product at 5mg/mL × 30mL. USA-manufactured via chemical synthesis and verified at 99%+ purity by HPLC and Mass Spectrometry. Pre-mixed liquid solution in 30mL or 60mL bottle with dropper; ready for laboratory use. Store at 15-25°C, away from direct light.
WARNING: For research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. For use by qualified research professionals only.
Forgot password?
Country: United States (US-only registration)
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Element CRP is a chemical supplier. Element CRP is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Element CRP is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
